Fluorescent cystoscopy for superficial tumors of the bladder: The contribution of hexaminolevulinate (Hexvix®) and a photodynamic diagnosis;Cystoscopie en fluorescence pour les tumeurs superficielles de vessie: Apport de l'hexaminolévulinate (Hexvix®) et du diagnostic photodynamique

Progres en Urologie - FMC

Volumn 19, Issue 1, 2009, Pages

  Vordos, Dimitri ^a   Ploussard, Guillaume ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Cystoscopy; Fluorescence; Superficial tumors of the bladder

Indexed keywords

EID: 62849113505     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1761-676X(09)70028-8     Document Type: Short Survey

References (15)

1. Irani J, Bernardini S, Bonnal JL et al. Tumeurs urothéliales. Prog Urol 2007;17:1065-98.
2. Jocham D, Stepp H, Waidelich R. Photodynamic diagnosis in urology : state-of-the-art. Eur Urol 2008;53:1138-48.
3. Marti A, Jichlinski P, Lange N et al. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J Urol 2003;170:428-32.
4. Jocham D, Witjes F, S. Wagner S et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging : a prospective, phase III multicenter study. J Urol 2005;174:862-6.
5. Kriegmair M, Zaak D, Rothenberger KH et al. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. J Urol 2002;168:475-8.
6. Fradet Y, Grossman HB, Gomella L et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer : a phase III, multicenter study. J Urol 2007;178:68-73.
7. Jichlinski P, Guillou L, Karlsen SJ et al. Hexyl aminolevulinate fluorescence cystoscopy : new diagnostic tool for photodiagnosis of superficial bladder cancer - a multicenter study. J Urol 2003;170:226-9.
8. Schmidbauer J, Witjes F, Schmeller N et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004;171:135-8.
9. Filbeck T, Pichlmeier U, Knuechel R et al. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. J Urol 2002;168:67-71.
10. Riedl CR, Daniltchenko D, Koenig F, et al. Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol 2001;165:1121-3.
11. Denzinger S, Burger M, Walter B. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis : 8-year results of prospective randomized study. Urology 2007;69:675-9.
12. Babjuk M, Soukup V, Petrik R et al. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. BJU Int 2005;96:798-802.
13. Daniltchenko DI, Riedl CR, Sachs MD et al. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer : 5-year results of a prospective randomized study. J Urol 2005;174:2129-33.
14. Grossman HB, Gomella L, Fradet Y, et al. PC B302/01 Study Group. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 2007;178:62-7.
15. Babjuk M, Oosterlinck W, Sylvester R et al. EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder. Eur Urol 2008;54:303-14.